Impact of renin–angiotensin–aldosterone system inhibitors on COVID-19

Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, the possible roles of renin–angiotensin system (RAS) inhibitors in COVID-19 have been debated as favorable, harmful, or neutral. Angiotensin-converting enzyme 2 (ACE2) not only is the entry route of severe acute respiratory syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuzawa, Yasushi, Kimura, Kazuo, Ogawa, Hisao, Tamura, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113925/
https://www.ncbi.nlm.nih.gov/pubmed/35581498
http://dx.doi.org/10.1038/s41440-022-00922-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113925/
https://www.ncbi.nlm.nih.gov/pubmed/35581498
http://dx.doi.org/10.1038/s41440-022-00922-3

Ejemplares similares